4
Changes in Ownership
NORTHWEST BIOTHERAPEUTICS INC Filed Acc 0001104659-20-080807
Options or other derivatives
- Chief Scientific Officer acquired 15,697,693 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BOYNTON ALTON L Chief Scientific Officer | 2020-07-02 | Grant or award · Options to purchase Common Stock, par value $0.001 | +15,697,693 | 15,697,693 | D | ||
Loading xslF345X03/tm2022243d7_4.xml…